anti-asthma glycosaminoglycans (Matrix)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameanti-asthma glycosaminoglycans (Matrix)
Drug Alias NameT-14
ClassificationSmall molecules > Carbohydrate > Oligosaccharide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMatrix Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMatrix Therapeutics
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic ObstructiveAsthma

Other Information

ATC CodeN/A
Related LinksN/A